Members of the Aerosol Drug Management Improvement Team (ADMIT)
Click the button to read the member CV or the toggle for more information about the member
“Inhalation therapy is critical for delivery of the most effective drugs in asthma and COPD but the techniques of inhaler therapy are often ignored in management. ADMIT aims to focus attention of inhalation devices and ensure that inhaled drugs are delivered more effectively in order to give a better therapeutic outcome.”
“Ensuring patients understand their illness as well as the recommended treatment and inhalation device is key to managing airways diseases and improving treatment outcomes. As a practicing pulmonary physician with a great clinical and scientific interest in asthma and COPD I am happy to work with my ADMIT colleagues to help both patients and health care providers to achieve these goals”
“I’m proud to belong to ADMIT, a very useful initiative to improve the awareness of the importance of education in asthma, managed by a well-qualified but friendly board of experts, who work very hard to realize new and innovative solutions for the management of asthma.
To realize materials and researches in this important topic in order to convince health workers and patients on the importance of a correct treatment of asthma and correct technique of use of inhalers. I’d like to make available some of the ADMIT initiatives to the Italian community with translations and adaptations of the material produced by the ADMIT group.”
“I am part of ADMIT because, as a medical professional who treats patients with severe obstructive airways diseases, particularly asthma and COPD, I am aware of the fundamental importance of the correct delivery of inhaled drugs to the airways if they are to be effective. This simple but vital requirement transcends all guidelines but is barely mentioned in national or global “initiatives”? for managing these diseases.
I hope through ADMIT to be able to bring this to the attention of the professional community so that a strategy for the appropriate prescription of inhaler devices which patients can use and want to use, and which deliver inhaled medication effectively and reliably is placed at the forefront of all management guidelines.”
“Inhaled therapy is a step-forward in the treatment of many airway diseases. However, there are too many different inhalation devices and a lot of problems of compliance with this therapy, either erratic or deliberate. By joining ADMIT I pursue to increase the awareness of this problem among the health-care professionals and contribute to generate top quality scientific evidence to improve the problem.”
 Borja Cosio Linkedin profile |
 Borja Cosio Researchgate profile |
“I’m proud to belong to ADMIT, a very useful initiative to improve the awareness of the importance of education in asthma, managed by a well-qualified but friendly board of experts, who work very hard to realize new and innovative solutions for the management of asthma.
To realize materials and researches in this important topic in order to convince health workers and patients on the importance of a correct treatment of asthma and correct technique of use of inhalers. I’d like to make available some of the ADMIT initiatives to the Italian community with translations and adaptations of the material produced by the ADMIT group.”
“I am proud to be part of ADMIT, because inhaled therapy is crucial for the management of respiratory diseases. Not many diseases have the opportunity to deliver the treatment so well to the target organ. But getting the medication into the lung requires patients. Firstly to take it and secondly to take it correctly. The interplay between the person who needs the medication and the technology interest me very much. Human behaviour is fascinating, and as general practitioner and researcher I want to improve the correct use of the treatment, the major aim of ADMIT.”
“I’m proud to belong to ADMIT, a very useful initiative to improve the awareness of the importance of education in asthma, managed by a well-qualified but friendly board of experts, who work very hard to realize new and innovative solutions for the management of asthma.
To realize materials and researches in this important topic in order to convince health workers and patients on the importance of a correct treatment of asthma and correct technique of use of inhalers. I’d like to make available some of the ADMIT initiatives to the Italian community with translations and adaptations of the material produced by the ADMIT group.”
“I am involved with admit because I see inhaler knowledge and correct use as the basis for managing patients with asthma and COPD. Management of these patients depends on efficient delivery of drugs via inhaler devices. Therefore it is fundamental importance that health care professionals have a thorough understanding of the different devices and that they know how to select and prescribe the right device/drug combination, and also to educate their patients how to use these. Being a member of ADMIT helps me to work towards achieving this goal.”
For my full Curriculum Vitae, please click here – http://www.consultmarklevy.com
“Since I wrote my MD thesis “Inhaler Use in Children with Asthma” I have had a great interest in inhaled therapy in children with asthma and the challenges associated the teaching children correct inhaler use. I want the level of asthma control in children to be improved. To achieve this better knowledge among health care providers and patients about correct inhaler use and choice in various age groups of children is critical.”
“Asthma and COPD are the most frequent respiratory diseases in the population, and have a major burden on individuals and on the society. Inhalation therapy is the cornerstone of the treatment of these obstructive lung diseases and has the potential for controlling asthma and alleviating COPD symptoms. However, the efficacy of inhaled treatments is frequently compromised by patients´ difficulties in the use of inhalation devices. This was first recognised with metered-dose inhalers and is now acknowledged with all types of inhalers. Thus, it is of utmost importance for all caregivers involved in this field to be aware of inhalers´ characteristics and technique, so that they can choose the right inhaler for the patient and provide him/her with the appropriate education and follow-up. Obviously, patients should also be involved in the care for their disease, and their information and education on inhalers is a major component of this involvement. All initiatives addressing this issue are welcomed and ADMIT is one of the most long-lasting and active.”
| Nicolas Roche Linkedin profile |
I am part of ADMIT because I believe that the correct use of inhalers is fundamental to keeping people with Asthma alive and for relieving symptoms in COPD. I also know there is poor practice in inhaler knowledge, use and teaching amongst health care professionals and patients.
I guess what I am trying to achieve with ADMIT is to work with like-minded individuals to improve the knowledge about inhalers and to spread the word about the best standards of practice.”
 @JaneScullion |
| @RespEM |
| Jane Scullion Linkedin profile |
“With many new devices and many new molecules in the treatment of patients with respiratory disorders it is becoming even more confusing for healthcare professionals in selecting the appropriate device/drug combination for their patients. I hope through ADMIT to contribute to the scientific evidence based assessment of inhalation devices and the rationale for making sense of the correct inhaler for use our patients in daily clinical practice.”
“I joined the ADMIT group because I am convinced that apart from the inhaled drugs themselves, benefit from and adherence to inhalation therapy of asthma and COPD patients depend to at least equal extents on the choice and the correct handling of the inhaler devices.
With the ADMIT group I try to achieve enhanced interest among patients, doctors and their trainers in this much neglected aspect of asthma and COPD treatment.”